Gallo, Honey Jane .
HRN: 27-53-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2025
AMPICILLIN 1GM (VIAL)
07/24/2025
07/26/2025
IV
2g
Q6hrs
Thinly Msaf
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: